{
    "fund_name": "iShares Healthcare Innovation UCITS ETF",
    "type": "ETF",
    "ucits": true,
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": [
        "Use of derivatives for investment purposes",
        "Optimized replication technique"
    ],
    "classification": "non-complex",
    "supporting_data": "The ETF primarily uses physical replication to track the STOXX Global Breakthrough Healthcare Index, which consists of equity securities. While the KIID mentions the use of financial derivative instruments (FDIs) for direct investment purposes and optimized replication techniques, these are used within the bounds of efficient portfolio management (EPM) and not for leverage or synthetic replication. The risk profile is rated 6 out of 7, but this is due to sector concentration and emerging market exposure rather than structural complexity. The ETF is UCITS-compliant, which imposes strict limits on derivative usage and counterparty risk. The absence of leverage, inverse strategies, or synthetic replication supports a non-complex classification.",
    "confidence": 85,
    "counter_argument": "Some may argue that the use of derivatives and optimized replication techniques could introduce complexity. However, these are standard practices in UCITS ETFs and are used to minimize tracking error rather than to create complex payoff structures. The derivatives are not used for leverage or to create non-linear returns, which are key triggers for complexity under MiFID II.",
    "risk_level": "The ETF has a risk rating of 6 out of 7, primarily due to its sector-specific focus and exposure to emerging markets, but this does not stem from structural complexity. The risks are clearly disclosed and align with the fund's investment objective."
}